Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Ping Shi

Showing results (21-30 of 219) with videos related to

Pageof 22
Sort By:
Ebiomedicine|August 19, 2020
Therapeutic potential of tricarboxylic acid cycle metabolite itaconate in cardiovascular diseasesChongzhe Yang, Tianxiao Liu, Guo-Ping Shi
International Journal of Molecular Sciences|May 27, 2015
Vasa vasorum in atherosclerosis and clinical significanceJunyan Xu, Xiaotong Lu, Guo-Ping Shi
Frontiers in Cell and Developmental Biology|August 9, 2021
Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and RemodelingXin Liu, Guo-Ping Shi, Junli Guo
Nature Reviews. Cardiology|January 6, 2017
Reply: The complexity of substance P-mediated mast cell activationGuo-Ping Shi, Ilze Bot, Petri T Kovanen
Nature Reviews. Cardiology|August 12, 2015
Mast cells in human and experimental cardiometabolic diseasesGuo-Ping Shi, Ilze Bot, Petri T Kovanen
Arteriosclerosis, Thrombosis, and Vascular Biology|August 9, 2014
Mast cells as effectors in atherosclerosisIlze Bot, Guo-Ping Shi, Petri T Kovanen
Translational Research : the Journal of Laboratory and Clinical Medicine|November 27, 2015
Interaction between allergic asthma and atherosclerosisCong-Lin Liu, Jin-Ying Zhang, Guo-Ping Shi
Pharmacology & Therapeutics|May 30, 2020
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patientsTianxiao Liu, Songyuan Luo, Peter Libby, et al.
Future Cardiology|December 25, 2012
Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysmsYanwen Qin, Xu Cao, Yaoguo Yang, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|January 12, 2020
Cysteinyl cathepsins in cardiovascular diseasesXian Zhang, Songyuan Luo, Minjie Wang, et al.
Pageof 22

Showing results (21-30 of 219) with videos related to

Sort By:
Pageof 22
Ebiomedicine|August 19, 2020
Therapeutic potential of tricarboxylic acid cycle metabolite itaconate in cardiovascular diseasesChongzhe Yang, Tianxiao Liu, Guo-Ping Shi
International Journal of Molecular Sciences|May 27, 2015
Vasa vasorum in atherosclerosis and clinical significanceJunyan Xu, Xiaotong Lu, Guo-Ping Shi
Frontiers in Cell and Developmental Biology|August 9, 2021
Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and RemodelingXin Liu, Guo-Ping Shi, Junli Guo
Nature Reviews. Cardiology|January 6, 2017
Reply: The complexity of substance P-mediated mast cell activationGuo-Ping Shi, Ilze Bot, Petri T Kovanen
Nature Reviews. Cardiology|August 12, 2015
Mast cells in human and experimental cardiometabolic diseasesGuo-Ping Shi, Ilze Bot, Petri T Kovanen
Arteriosclerosis, Thrombosis, and Vascular Biology|August 9, 2014
Mast cells as effectors in atherosclerosisIlze Bot, Guo-Ping Shi, Petri T Kovanen
Translational Research : the Journal of Laboratory and Clinical Medicine|November 27, 2015
Interaction between allergic asthma and atherosclerosisCong-Lin Liu, Jin-Ying Zhang, Guo-Ping Shi
Pharmacology & Therapeutics|May 30, 2020
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patientsTianxiao Liu, Songyuan Luo, Peter Libby, et al.
Future Cardiology|December 25, 2012
Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysmsYanwen Qin, Xu Cao, Yaoguo Yang, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|January 12, 2020
Cysteinyl cathepsins in cardiovascular diseasesXian Zhang, Songyuan Luo, Minjie Wang, et al.
Pageof 22